Funder: National Institutes of Health (NIH) Office of the Director (OD), NIH Common Fund, and NIH National Center For Complementary & Integrative Health (NCCIH)
Program: NIH Director’s New Innovator Award Program (DP2)
Grant number: DP2AT012346
The NIH Director’s New Innovator Award Program supports exceptionally creative early career investigators who propose innovative, high-impact projects in the biomedical, behavioral or social sciences within the NIH mission. Our work is on Deciphering the crosstalk between bacteria and their mammalian hosts.
Funder: University of Colorado
Program: AB Nexus Grant Program
The AB Nexus Grant Program supports collaborative research between CU Boulder and CU Anschutz Medical School campuses. Our work is on Nucleotide Second Messengers at the Host-Pathogen Interface, in collaboration with Dr. Kelly S. Doran, PhD, (Department of Immunology and Microbiology), CU Anschutz.
Funder: Boettcher Foundation
Program: Webb-Waring Biomedical Research Awards Program
The Boettcher Foundation has named Aaron and 7 others to the 2022 class of Boettcher Investigators through the Boettcher Foundation’s Webb-Waring Biomedical Research Awards Program. The prestigious award supports promising, early career scientific researchers, allowing them to advance their independent research in Colorado and compete for major federal and private awards in the future. Each Boettcher Investigator will receive a $235,000 grant to support up to three years of biomedical research.
Funder: Mallinckrodt Foundation
Program: Mallinckrodt Foundation Grant
The Edward Mallinckrodt, Jr. Foundation supports early-stage biomedical investigators engaged in basic and translational research that has the potential to make fundamental advances in biomedical science.